glp 1 and psoriatic arthritis Glucagon-like peptide its receptor agonists for the treatment of rheumatic diseases glp-1 for psoriatic arthritis The

In addition to GLP-1R/GCGR dual agonists, a chimeric peptide as dual GLP-1/GIP receptor agonists has been developed, showing enhanced therapeutic potential for obesity and related comorbidities

Intranasal delivery, bypassing the BBB via neural pathways, has emerged as an alternative, particularly effective for peptide-modified or mucoadhesive NPs delivering hydrophilic or biologic agents [63]

These materials are expressly forbidden for any form of human or animal use, ingestion, or administration

950 mg (Trans-Resveratrol (Japanese Knotweed Ext.) (Polygonum cuspidatum) (root), BroccoRaphanin Activated Broccoli Raffinate seed (Brassica oleracea), Sulforaphane Glucosinolate 10%, Myrosinase Enzyme 23% (Thioglucoside glucohydrolase), Turmeric (Curcuma longa) (root) (Std

Common adverse effects include nausea, vomiting, diarrhea, and decreased appetite